Reduce counterfeit drugs and protect the brand
Pfizer fights back against fake drugs
Due to the threats and dangers associated with fake drugs, WHO has identified the issue as one of the urgent health challenges for the next decade. Kezzler was chosen by Pfizer Hong Kong to provide brand protection that is projected to reduce counterfeits by 40%.
This is just an abstract of the case study. To read the full case study register your mail and we will send it to you.
As maker of one of the most heavily counterfeited drugs in the world, Pfizer projected significant revenue losses in Asian and certain African markets. Additionally, the counterfeited pills came with severe health risks, posing a threat to the Pfizer brand and consumer safety. Pfizer Hong Kong wanted a simple way for all parties to be able to verify the product in hand as being genuine, helping to eliminate concerns related to counterfeit products on the market.
Due to the threats and dangers associated with fake drugs, WHO has identified the issue as one of the urgent health challenges for the next decade.
Pfizer pass label
The application of unique, secure and traceable identities enables consumers, Pfizer, and other supply chain stakeholders to verify every pack’s authenticity. The unique identities (UIDs) can be checked with a mobile phone or online to receive confirmation that the pack is genuine. The project resulted in a 40% drop in counterfeit medications in one year and the solution was extended to cover additional product lines and countries.
Main Reasons for selecting Kezzler for a brand protection project:
To read more, download the complete case study
Stop counterfeit products and illicit trade, by giving each of your products their own digital Kezzler identity in mass volume and at low cost.
Piet de Vriendt
Sr. Business Development Manager